Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes?

Paola Morales1, Diego Bustamante, Pablo Espina-Marchant

  • 1Programme of Molecular & Clinical Pharmacology, ICBM, Medical Faculty, University of Chile, PO Box 70.000, Santiago 7, Chile.

The EPMA Journal
|December 4, 2012
PubMed

Insights

Perinatal asphyxia, a condition from prolonged delivery, can cause neurological issues in infants. This review explores biomarkers, sequelae, and therapeutic targets for better prediction and treatment of birth asphyxia outcomes.

Area of Science:

  • Neuroscience
  • Neonatology
  • Biochemistry

Background:

  • Perinatal asphyxia remains a significant cause of infant neurological sequelae despite advances in perinatal care.
  • The severity of neurological damage is influenced by insult extent, re-oxygenation, and brain region development.

Purpose of the Study:

  • To review current understanding of perinatal asphyxia pathophysiology.
  • To identify early diagnostic biomarkers and novel therapeutic targets for improved infant outcomes.

Main Methods:

  • Literature review of perinatal asphyxia research.
  • Analysis of biomarkers, neurological sequelae, neurocircuitry, molecular pathways, and neuroinflammation.
  • Discussion of endogenous brain rescue mechanisms and therapeutic strategies.

Main Results:

  • Progress has been made in understanding asphyxia, but predictive diagnostics and personalized therapies are nascent.
  • Emphasis is shifting towards early, non-invasive diagnosis and identifying new therapeutic targets.

Conclusions:

  • Early non-invasive diagnosis and targeted therapies are crucial for mitigating perinatal asphyxia effects.
  • Further research into biomarkers and therapeutic targets can improve individual outcomes for affected infants.